Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study

Gary M Woods1, Ruchika Sharma2, Susan Creary3

  • 1Division of Pediatric Hematology/Oncology, Children's Hospital of the King's Daughters, Norfolk, VA.

Insights

Nearly 3% of children with sickle cell disease (SCD) experienced venous thromboembolism (VTE). Central venous catheter (CVC) use was identified as an independent risk factor for VTE in this pediatric population.

Area of Science:

  • Hematology
  • Pediatric Thrombosis
  • Sickle Cell Disease Research

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder associated with an increased risk of venous thromboembolism (VTE).
  • Understanding VTE incidence and risk factors in pediatric SCD patients is crucial for effective prevention and management strategies.

Purpose of the Study:

  • To determine the cumulative incidence of VTE in children with SCD.
  • To identify clinical risk factors associated with VTE development in this patient group.

Main Methods:

  • Retrospective chart review of pediatric patients (0-21 years) with SCD at a single institution over a 6-year period.
  • Data collected included VTE diagnosis, demographics, SCD genotype, clinical complications, central venous catheter (CVC) placement, and thrombophilia testing.

Main Results:

  • The cumulative incidence of VTE was 2.9% (12/414) among children with SCD.
  • Central venous catheter (CVC) presence was the only independent risk factor for VTE on multivariable analysis (OR 33.8).
  • Other univariate risk factors included hemoglobin SS genotype, central nervous system vasculopathy, chronic transfusion therapy, and older age.

Conclusions:

  • Approximately 3% of children with SCD at this institution experienced VTE.
  • Central venous catheter (CVC) placement is a significant independent predictor of VTE in children with sickle cell disease.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
354
Venous Return01:04

Venous Return

The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
12.5K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
485
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
378